Oncoinvent ASA: Second half 2025 results

Oncoinvent ASA Norway

after the live sending.

Reporting material:

Oncoinvent 2H 2025 reportOncoinvent 2H25 presentation

The reporting material are also available in the Investor Relations section of the Company's website at www.oncoinvent.com.

For further information, please contact:
Oystein Soug, Chief Executive Officer
Email: [e-mail]

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange announcement was published by Renate Birkeli, Director Investor Relations, on behalf of the Company, at the time and date stated above in this announcement.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/oncoinvent-asa/r/oncoinvent-asa--second-half-2025-results,c4313178

The following files are available for download:

https://mb.cision.com/Public/15728/4313178/b79ae34c93871998.pdf

20260226 Oncoinvent 2H 2025 report

https://mb.cision.com/Public/15728/4313178/b034e378391f908e.pdf

20260226 Oncoinvent 2H25 presentation

 

View original content:https://www.prnewswire.co.uk/news-releases/oncoinvent-asa-second-half-2025-results-302697994.html